US lawmakers seek to overturn SEC's cryptocurrency accounting rules
According to CoinDesk, members of the US Congress are attempting to repeal a controversial accounting notice by the Securities and Exchange Commission (SEC) that imposes restrictions on companies wishing to hold customer crypto assets. Senator Cynthia Lummis (R-Wyo.), along with Representatives Wiley Nickel (D-N.C.) and Mike Flood (R-Neb.), introduced matching resolutions in the Senate and House on Thursday formally opposing this accounting rule and determining its lack of legal effect. SEC's Staff Accounting Bulletin No. 121 for 2022 (SAB 121) requires companies holding customer cryptocurrencies to include them on their own balance sheets, which could force banks wanting to hold crypto assets to maintain what they consider burdensome capital requirements as a hedge against risk.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test
Goldman Sachs (GS.US) and Apollo Global Management (APO.US) are in talks with Wall Street investors to begin selling portions of a roughly $40 billion chip financing deal for SpaceX (SPCX.US).
